BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38541089)

  • 21. The effects of
    Cheng Y; Liu Y; Lin L; Li D; Peng L; Zheng K; Tao J; Li M
    Ren Fail; 2024 Dec; 46(1):2295425. PubMed ID: 38178377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary levels of pro-fibrotic transglutaminase 2 (TG2) may help predict progression of chronic kidney disease.
    Da Silva Lodge M; Pullen N; Pereira M; Johnson TS
    PLoS One; 2022; 17(1):e0262104. PubMed ID: 35041708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on the relationship between lipoprotein (a) and diabetic kidney disease.
    Wang A; Zhang S; Li Y; Zhu F; Xie B
    J Diabetes Complications; 2023 Jan; 37(1):108378. PubMed ID: 36549039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary glycated uromodulin in diabetic kidney disease.
    Chang CC; Chen CY; Huang CH; Wu CL; Wu HM; Chiu PF; Kor CT; Chen TH; Chang GD; Kuo CC; Wen HC; Huang CY; Chang CH
    Clin Sci (Lond); 2017 Aug; 131(15):1815-1829. PubMed ID: 28592554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Renal Impairment in Patients with Diabetic Kidney Disease by Integrated Chinese and Western Medicine.
    Qu YL; Dong ZY; Cheng HM; Liu Q; Wang Q; Yang HT; Mao YH; Li JJ; Liu HF; Geng YQ; Huang W; Liu WH; Xie HD; Peng F; Li S; Jiang SS; Li WZ; Duan SW; Feng Z; Zhang WG; Liu YN; Tian JZ; Chen XM
    Chin J Integr Med; 2023 Apr; 29(4):308-315. PubMed ID: 35679002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney disease.
    Lerma E; White WB; Bakris G
    Postgrad Med; 2023 Apr; 135(3):224-233. PubMed ID: 35392754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic kidney disease-related osteoporosis is associated with incident frailty among patients with diabetic kidney disease: a propensity score-matched cohort study.
    Chao CT; Wang J; Huang JW; Chan DC; Hung KY; Chien KL;
    Osteoporos Int; 2020 Apr; 31(4):699-708. PubMed ID: 32103279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening candidate diagnostic biomarkers for diabetic kidney disease.
    Huang X; Zhang H; Liu J; Yang X; Liu Z
    J Clin Lab Anal; 2024 Feb; 38(3):e25000. PubMed ID: 38299750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
    Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S;
    BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of chronic kidney disease definition on assessment of its incidence and risk factors in patients with newly diagnosed type 1 and type 2 diabetes in the UK: A cohort study using primary care data from the United Kingdom.
    González-Pérez A; Saéz ME; Vizcaya D; Lind M; García Rodríguez LA
    Prim Care Diabetes; 2020 Aug; 14(4):381-387. PubMed ID: 31791904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes of patients with type 2 diabetes attending a multidisciplinary diabetes kidney disease clinic.
    Low S; Lim SC; Wang J; Yeoh LY; Liu YL; Lim EK; Shao YL; Chui W; Fun S; Chua CL; Subramaniam T; Sum CF
    J Diabetes; 2018 Jul; 10(7):572-580. PubMed ID: 29154443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease.
    Zhou Y; Ren J; Li P; Ma R; Zhou M; Zhang N; Kong X; Hu Z; Xiao X
    Arch Med Res; 2019 Jul; 50(5):249-256. PubMed ID: 31593848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary growth differentiation factor 15 predicts renal function decline in diabetic kidney disease.
    Oshita T; Watanabe S; Toyohara T; Kujirai R; Kikuchi K; Suzuki T; Suzuki C; Matsumoto Y; Wada J; Tomioka Y; Tanaka T; Abe T
    Sci Rep; 2023 Aug; 13(1):12508. PubMed ID: 37532799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Status Quo and Research Progress in Diagnosis and Treatment of Patients With Diabetes Mellitus and Chronic Kidney Disease].
    Dai PY; Yuan QJ; Peng ZZ; Xie YY; Tao LJ; Huang L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):987-996. PubMed ID: 38173112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary mRNA Signatures as Predictors of Renal Function Decline in Patients With Biopsy-Proven Diabetic Kidney Disease.
    Lee YH; Seo JW; Kim M; Tae D; Seok J; Kim YG; Lee SH; Kim JS; Hwang HS; Jeong KH; Moon JY
    Front Endocrinol (Lausanne); 2021; 12():774436. PubMed ID: 34858345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey.
    Duan JY; Duan GC; Wang CJ; Liu DW; Qiao YJ; Pan SK; Jiang DK; Liu Y; Zhao ZH; Liang LL; Tian F; Liu ZS
    BMC Nephrol; 2020 Apr; 21(1):115. PubMed ID: 32245423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Emphasis on the diagnosis of chronic kidney disease in diabetes mellitus].
    Ding HL; Luo HJ; Xu DP; Li GS
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(10):687-690. PubMed ID: 33721944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary NGAL and RBP Are Biomarkers of Normoalbuminuric Renal Insufficiency in Type 2 Diabetes Mellitus.
    Li A; Yi B; Liu Y; Wang J; Dai Q; Huang Y; Li YC; Zhang H
    J Immunol Res; 2019; 2019():5063089. PubMed ID: 31637265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.